Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1298079,Activ2,Activity QTL 2,9.5,0.000001,voluntary movement trait (VT:0003491),rearing measurement (CMO:0001515),8,41866876,86866876,Rat,n/a,region,qtl 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,59948935,154902892,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,59948935,154902892,Rat,n/a,region,qtl 1000,12879882,Am8,Aortic mass QTL 8,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),8,43296169,98968765,Rat,n/a,region,qtl 1000,634335,Anxrr16,Anxiety related response QTL 16,7.22,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,93308457,167139447,Rat,n/a,region,qtl 1000,6478693,Anxrr32,Anxiety related response QTL 32,,0.00092,locomotor behavior trait (VT:0001392),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",4,144639524,182687754,Rat,n/a,region,qtl 1000,6478700,Anxrr33,Anxiety related response QTL 33,,0.00896,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,144639524,182687754,Rat,n/a,region,qtl 1000,6478718,Anxrr34,Anxiety related response QTL 34,,0.00896,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,144639524,182687754,Rat,n/a,region,qtl 1000,6478748,Anxrr42,Anxiety related response QTL 42,,0.28008,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,144639524,182687754,Rat,n/a,region,qtl 1000,6478754,Anxrr43,Anxiety related response QTL 43,,0.14035,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,144639524,182687754,Rat,n/a,region,qtl 1000,6478760,Anxrr45,Anxiety related response QTL 45,,0.06717,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110870972,155870972,Rat,n/a,region,qtl 1000,6478763,Anxrr46,Anxiety related response QTL 46,,0.07428,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110870972,155870972,Rat,n/a,region,qtl 1000,6478778,Anxrr51,Anxiety related response QTL 51,,0.25384,locomotor behavior trait (VT:0001392),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",4,124778595,169778595,Rat,n/a,region,qtl 1000,12798519,Anxrr54,Anxiety related response QTL 54,2.54,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,114627026,159627026,Rat,n/a,region,qtl 1000,12798525,Anxrr57,Anxiety related response QTL 57,3.21,0.05,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,147278504,167139601,Rat,n/a,region,qtl 1000,1578674,Bmd12,Bone mineral density QTL 12,3.8,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),4,135699135,180699135,Rat,n/a,region,qtl 1000,1554321,Bmd3,Bone mineral density QTL 3,7.9,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),8,40952565,123900184,Rat,n/a,region,qtl 1000,2293659,Bmd35,Bone mineral density QTL 35,4.5,0.0001,femur strength trait (VT:0010010),femoral neck ultimate force (CMO:0001703),4,137755016,181392681,Rat,n/a,region,qtl 1000,2293697,Bmd39,Bone mineral density QTL 39,,,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),8,54043744,98968765,Rat,n/a,region,qtl 1000,631683,Bp116,Blood pressure QTL 116,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,124303370,169303370,Rat,n/a,region,qtl 1000,1331738,Bp209,Blood pressure QTL 209,2.979,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,138503169,179293946,Rat,n/a,region,qtl 1000,1331744,Bp217,Blood pressure QTL 217,3.398,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,30848154,58482492,Rat,n/a,region,qtl 1000,1358906,Bp253,Blood pressure QTL 253,4,0.0004,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),8,40713066,93965294,Rat,n/a,region,qtl 1000,1358896,Bp262,Blood pressure QTL 262,2.89,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),8,27205715,99103503,Rat,n/a,region,qtl 1000,1359033,Bp273,Blood pressure QTL 273,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,30848154,61290444,Rat,n/a,region,qtl 1000,2301402,Bp316,Blood pressure QTL 316,,0.005,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),8,53968765,98968765,Rat,n/a,region,qtl 1000,61353,Bp35,Blood pressure QTL 35,,0.001,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),8,30848154,61290444,Rat,n/a,region,qtl 1000,61353,Bp35,Blood pressure QTL 35,,0.001,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),8,30848154,61290444,Rat,n/a,region,qtl 1000,61353,Bp35,Blood pressure QTL 35,,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,30848154,61290444,Rat,n/a,region,qtl 1000,61353,Bp35,Blood pressure QTL 35,,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,30848154,61290444,Rat,n/a,region,qtl 1000,10402857,Bp380,Blood pressure QTL 380,,0.95,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),8,53968765,98968765,Rat,n/a,region,qtl 1000,61358,Bp39,Blood pressure QTL 39,2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,35551938,80551938,Rat,n/a,region,qtl 1000,70161,Bp62,Blood pressure QTL 62,2.9,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,42692684,90165460,Rat,n/a,region,qtl 1000,70197,BpQTLcluster8,Blood pressure QTL cluster 8,3.482,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),8,46531639,119088624,Rat,n/a,region,qtl 1000,70197,BpQTLcluster8,Blood pressure QTL cluster 8,3.482,,arterial blood pressure trait (VT:2000000),absolute change in systolic blood pressure (CMO:0000607),8,46531639,119088624,Rat,n/a,region,qtl 1000,70197,BpQTLcluster8,Blood pressure QTL cluster 8,3.482,,arterial blood pressure trait (VT:2000000),pulse pressure (CMO:0000292),8,46531639,119088624,Rat,n/a,region,qtl 1000,70197,BpQTLcluster8,Blood pressure QTL cluster 8,3.482,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),8,46531639,119088624,Rat,n/a,region,qtl 1000,5684973,Bss100,Bone structure and strength QTL 100,4.7,,tibia area (VT:1000281),tibia area measurement (CMO:0001382),8,50095249,82460899,Rat,n/a,region,qtl 1000,7207480,Bss105,Bone structure and strength QTL 105,8.1,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),4,109827074,154827074,Rat,n/a,region,qtl 1000,1549832,Bss3,Bone structure and strength QTL 3,11,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),4,109827074,154827074,Rat,n/a,region,qtl 1000,2313086,Bss60,Bone structure and strength QTL 60,4.1,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),8,50095249,82460899,Rat,n/a,region,qtl 1000,2313088,Bss75,Bone structure and strength QTL 75,3.1,0.0001,body length (VT:0001256),"body length, nose to rump (CMO:0000079)",8,30848154,82460899,Rat,n/a,region,qtl 1000,2313057,Bss76,Bone structure and strength QTL 76,3,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),8,30848154,82460899,Rat,n/a,region,qtl 1000,2313067,Bss77,Bone structure and strength QTL 77,3.1,0.0001,tibia size trait (VT:0100001),tibia midshaft endosteal cross-sectional area (CMO:0001716),8,30848154,82460899,Rat,n/a,region,qtl 1000,2313046,Bss78,Bone structure and strength QTL 78,3.5,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),8,30848154,82460899,Rat,n/a,region,qtl 1000,4889938,Bss89,Bone structure and strength QTL 89,3.8,,tibia size trait (VT:0100001),tibia cortical bone volume (CMO:0001725),8,50095249,82460899,Rat,n/a,region,qtl 1000,7411558,Bw133,Body weight QTL 133,13.84,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),4,125590636,170590636,Rat,n/a,region,qtl 1000,12879878,Bw183,Body weight QTL 183,,0.001,body mass (VT:0001259),body weight (CMO:0000012),8,43296169,98968765,Rat,n/a,region,qtl 1000,1331837,Bw23,Body weight QTL 23,4.19,0.00007,body mass (VT:0001259),body weight (CMO:0000012),8,46531722,99083736,Rat,n/a,region,qtl 1000,1358912,Bw51,Body weight QTL 51,2.95,,body mass (VT:0001259),body weight (CMO:0000012),8,51351728,107062046,Rat,n/a,region,qtl 1000,1582243,Bw66,Body weight QTL 66,3.4,0.0048,body mass (VT:0001259),body weight (CMO:0000012),8,54237644,85365202,Rat,n/a,region,qtl 1000,61422,Cia13,Collagen induced arthritis QTL 13,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,132642577,167139601,Rat,n/a,region,qtl 1000,634342,Cia24,Collagen induced arthritis QTL 24,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,146565735,175236377,Rat,n/a,region,qtl 1000,61451,Ciaa4,CIA Autoantibody QTL 4,3.1,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),4,126395976,167139601,Rat,n/a,region,qtl 1000,12879880,Cm100,Cardiac mass QTL 100,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),8,43296169,98968765,Rat,n/a,region,qtl 1000,12879881,Cm101,Cardiac mass QTL 101,,0.001,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),8,43296169,98968765,Rat,n/a,region,qtl 1000,724535,Cm18,Cardiac mass QTL 18,2.6,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),4,118856416,163856416,Rat,n/a,region,qtl 1000,1300177,Cm2,Cardiac mass QTL 2,3.65,,heart mass (VT:0007028),heart weight (CMO:0000017),8,54259986,100382532,Rat,n/a,region,qtl 1000,1358907,Cm40,Cardiac mass QTL 40,1.89,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),8,27205715,99103503,Rat,n/a,region,qtl 1000,11556286,Cm81,Cardiac mass QTL 81,,0.01,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),8,30848154,61290444,Rat,n/a,region,qtl 1000,12879879,Cm99,Cardiac mass QTL 99,,0.001,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),8,43296169,98968765,Rat,n/a,region,qtl 1000,61446,Coreg2,Compensatory renal growth QTL 2,3.5,,kidney mass (VT:0002707),compensatory renal growth score (CMO:0001894),4,148423102,157580971,Rat,n/a,region,qtl 1000,1581557,Eae16,Experimental allergic encephalomyelitis QTL 16,3.8,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046),8,8462195,110921472,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,44463720,155883716,Rat,n/a,region,qtl 1000,1582222,Epfw2,Epididymal fat weight QTL 2,3.2,0.0005,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),8,31737729,76737729,Rat,n/a,region,qtl 1000,1576316,Ept5,Estrogen-induced pituitary tumorigenesis QTL 5,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),4,83428419,177635233,Rat,n/a,region,qtl 1000,1358202,Gluco11,Glucose level QTL 11,2.4,0.02,adipocyte glucose uptake trait (VT:0004185),absolute change in adipocyte glucose uptake (CMO:0000873),4,85379421,167139601,Rat,n/a,region,qtl 1000,2303564,Gluco43,Glucose level QTL 43,3,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),8,26130187,71130187,Rat,n/a,region,qtl 1000,2303570,Gluco48,Glucose level QTL 48,2,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),8,49805831,94805831,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,11320076,180699135,Rat,n/a,region,qtl 1000,737824,Hcar10,Hepatocarcinoma resistance QTL 10,2.9,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),8,40713066,82925667,Rat,n/a,region,qtl 1000,631664,Hcar3,Hepatocarcinoma resistance QTL 3,2.9,0.0005,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),8,54237644,99103503,Rat,n/a,region,qtl 1000,634347,Hcar8,Hepatocarcinoma resistance QTL 8,5.8,,liver integrity trait (VT:0010547),liver tumorous lesion area to total liver area ratio (CMO:0001075),4,123143783,168143783,Rat,n/a,region,qtl 1000,737821,Hcar9,Hepatocarcinoma resistance QTL 9,3.7,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,109866907,167139601,Rat,n/a,region,qtl 1000,1331759,Hrtrt13,Heart rate QTL 13,3.54628,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,110275411,168266883,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,64528739,157573521,Rat,n/a,region,qtl 1000,631842,Inf1,Infertility severity QTL 1,4.1,0.001,seminal gland mass (VT:0010524),seminal vesicle wet weight (CMO:0001603),8,22662330,67662330,Rat,n/a,region,qtl 1000,2303572,Insul13,Insulin level QTL 13,2,,blood insulin amount (VT:0001560),blood insulin level (CMO:0000349),8,26130187,71130187,Rat,n/a,region,qtl 1000,1358892,Kidm26,Kidney mass QTL 26,3.69,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),8,27205715,99103503,Rat,n/a,region,qtl 1000,1582254,Kidm31,Kidney mass QTL 31,3,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),8,54237644,85365202,Rat,n/a,region,qtl 1000,1582237,Kidm34,Kidney mass QTL 34,4,0.0001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),4,148090542,168069246,Rat,n/a,region,qtl 1000,10401796,Kidm48,Kidney mass QTL 48,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),4,145568712,182687754,Rat,n/a,region,qtl 1000,12879883,Kidm65,Kidney mass QTL 65,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),8,43296169,98968765,Rat,n/a,region,qtl 1000,1578765,Klgr1,Kidney lesion grade QTL 1,3.3,0.0001,kidney morphology trait (VT:0002135),organ lesion measurement (CMO:0000677),8,30848154,101699754,Rat,n/a,region,qtl 1000,631271,Lecl1,Lens clarity QTL 1,,0.001,lens clarity trait (VT:0001304),age of onset/diagnosis of cataract (CMO:0001584),8,18984168,84531599,Rat,n/a,region,qtl 1000,61373,Mcs4,Mammary carcinoma susceptibility QTL 4,1.1,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),8,16290444,61290444,Rat,n/a,region,qtl 1000,1549908,Neudeg1,Neurodegradation QTL 1,5.5,0,nervous system integrity trait (VT:0010566),logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986),8,30188867,94457446,Rat,n/a,region,qtl 1000,61464,Niddm11,Non-insulin dependent diabetes mellitus QTL 11,3.1,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),8,35582032,80582032,Rat,n/a,region,qtl 1000,1331838,Niddm61,Non-insulin dependent diabetes mellitus QTL 61,3.53,0.0004,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),8,36469535,99083736,Rat,n/a,region,qtl 1000,61362,Oia2,Oil induced arthritis QTL 2,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,138503169,173369699,Rat,n/a,region,qtl 1000,1298524,Oia8,Oil induced arthritis QTL 8,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,138503169,173369699,Rat,n/a,region,qtl 1000,737978,Pia23,Pristane induced arthritis QTL 23,5.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131730738,167139601,Rat,n/a,region,qtl 1000,631511,Pia7,Pristane induced arthritis QTL 7,4.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131730738,167139601,Rat,n/a,region,qtl 1000,724558,Plsm2,Polydactyly-luxate syndrome (PLS) morphotypes QTL 2,,0.0003,hindlimb integrity trait (VT:0010563),hind foot phalanges count (CMO:0001949),4,132422778,177422778,Rat,n/a,region,qtl 1000,1578755,Pur5,Proteinuria QTL 5,3.3,0.0001,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),8,30848154,101699754,Rat,n/a,region,qtl 1000,1300146,Rf17,Renal function QTL 17,2.9,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),8,28242912,73242912,Rat,n/a,region,qtl 1000,1331769,Rf39,Renal function QTL 39,3.871,,urine output (VT:0003620),timed urine volume (CMO:0000260),8,41866876,75097878,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,59948935,154902892,Rat,n/a,region,qtl 1000,1298065,Scl16,Serum cholesterol level QTL 16,3.8,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),8,30856404,75856404,Rat,n/a,region,qtl 1000,1549827,Scl46,Serum cholesterol level QTL 46,3.5,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),4,132396220,177396220,Rat,n/a,region,qtl 1000,2316950,Scl66,Serum cholesterol level QTL 66,4.1,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),8,30848259,105647037,Rat,n/a,region,qtl 1000,1331802,Srn5,Serum renin concentration QTL 5,3.045,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),4,119428175,157578333,Rat,n/a,region,qtl 1000,631650,Stl6,Serum triglyceride level QTL 6,4,0.0019,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),8,10378157,112202585,Rat,n/a,region,qtl 1000,631216,Stl9,Serum triglyceride level QTL 9,4.71,0.0001,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),8,41867010,70386132,Rat,n/a,region,qtl 1000,1558646,Swd5,Spike wave discharge measurement QTL 5,3.45,0.00036,brain electrophysiology trait (VT:0010557),brain spike-and-wave discharge frequency (CMO:0001742),8,14906751,59906751,Rat,n/a,region,qtl 1000,724514,Uae15,Urinary albumin excretion QTL 15,2.9,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),8,29502665,70386295,Rat,n/a,region,qtl 1000,731182,Uae24,Urinary albumin excretion QTL 24,6.4,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),8,19331152,93965294,Rat,n/a,region,qtl 1000,1578769,Uae31,Urinary albumin excretion QTL 31,3.3,0.001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),8,30848154,101699754,Rat,n/a,region,qtl 1000,2303623,Vencon2,Ventilatory control QTL 2,3.8,,respiration trait (VT:0001943),minute ventilation (CMO:0000132),4,135204660,180204660,Rat,n/a,region,qtl 1000,8662823,Vetf5,Vascular elastic tissue fragility QTL 5,1.9,,artery integrity trait (VT:0010639),patent ductus arteriosus score (CMO:0002566),8,28242912,99525068,Rat,n/a,region,qtl 1000,70177,Xhs1,X-ray hypersensitivity QTL 1,25.1,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,82798864,152731274,Rat,n/a,region,qtl